| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.3 | 1e-14 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.25 | 4e-12 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.26 | 8e-12 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.22 | 9e-11 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.23 | 1e-10 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | -0.21 | 1e-08 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.33 | 7e-08 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-07 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.19 | 7e-07 |